Human cell manufacturer Cellular Dynamics sets terms for $50 million IPO

By
A A A

Cellular Dynamics International, which develops and manufactures functioning human cells in large quantities, announced terms for its IPO on Wednesday. The Madison, WI-based company plans to raise $50 million by offering 3.8 million shares at a price range of $12 to $14. At the midpoint of the proposed range, Cellular Dynamics International would command a fully diluted market value of $212 million.

Cellular Dynamics International, which was founded in 2004 and booked $8 million in sales for the 12 months ended March 31, 2013, plans to list on the NASDAQ under the symbol ICEL. Cellular Dynamics International initially filed confidentially on February 26, 2013. J.P. Morgan is the sole bookrunner on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: ICEL

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Quick on Your Feet
Quick on Your Feet                  
Early Entrepreneurship
Early Entrepreneurship              

Stocks

Referenced

Most Active by Volume

48,099,947
  • $16.09 ▲ 0.50%
40,277,806
  • $102.50 ▲ 0.24%
40,236,499
  • $19.57 ▲ 2.35%
31,092,510
  • $49.75 ▲ 0.65%
30,795,218
  • $34.92 ▲ 0.78%
29,910,855
  • $3.63 ▲ 0.83%
24,019,154
  • $13.06 ▼ 0.38%
23,753,906
  • $74.82 ▲ 1.31%
As of 8/29/2014, 04:04 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com